Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
3.830
-0.540 (-12.36%)
At close: Apr 1, 2025, 4:00 PM
4.019
+0.189 (4.93%)
After-hours: Apr 1, 2025, 4:11 PM EDT
Adverum Biotechnologies Stock Forecast
ADVM's stock price has decreased by -73.06% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Adverum Biotechnologies stock have an average target of 27.83, with a low estimate of 10 and a high estimate of 40. The average target predicts an increase of 626.63% from the current stock price of 3.83.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 19, 2024.
Analyst Ratings
The average analyst rating for Adverum Biotechnologies stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +683.29% | Nov 19, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $12 → $10 | Hold | Maintains | $12 → $10 | +161.10% | Nov 5, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +944.39% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +683.29% | Aug 13, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +213.32% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
1.02M
from 3.60M
Decreased by -71.67%
Revenue Next Year
12.88M
from 1.02M
Increased by 1,162.55%
EPS This Year
-5.11
from -11.62
EPS Next Year
-4.77
from -5.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.1M | 105.0M | 948,150 | |||
| Avg | 1.0M | 12.9M | 307,020 | |||
| Low | 980,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -70.8% | 10,194.1% | -92.6% | |||
| Avg | -71.7% | 1,162.5% | -97.6% | |||
| Low | -72.8% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -4.85 | -0.22 | -0.18 | |||
| Avg | -5.11 | -4.77 | -4.25 | |||
| Low | -5.30 | -6.08 | -6.42 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.